GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palatin Technologies Inc (LTS:0KF3) » Definitions » Cyclically Adjusted PB Ratio

Palatin Technologies (LTS:0KF3) Cyclically Adjusted PB Ratio : 0.46 (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Palatin Technologies Cyclically Adjusted PB Ratio?

As of today (2024-06-08), Palatin Technologies's current share price is $2.05. Palatin Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $4.46. Palatin Technologies's Cyclically Adjusted PB Ratio for today is 0.46.

The historical rank and industry rank for Palatin Technologies's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0KF3' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.27   Med: 0.91   Max: 3.84
Current: 0.44

During the past years, Palatin Technologies's highest Cyclically Adjusted PB Ratio was 3.84. The lowest was 0.27. And the median was 0.91.

LTS:0KF3's Cyclically Adjusted PB Ratio is ranked better than
75.95% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs LTS:0KF3: 0.44

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Palatin Technologies's adjusted book value per share data for the three months ended in Mar. 2024 was $0.098. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.46 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Palatin Technologies Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Palatin Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palatin Technologies Cyclically Adjusted PB Ratio Chart

Palatin Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.09 1.67 2.05 0.92 0.38

Palatin Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.38 0.29 0.83 0.41

Competitive Comparison of Palatin Technologies's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Palatin Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Palatin Technologies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palatin Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Palatin Technologies's Cyclically Adjusted PB Ratio falls into.



Palatin Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Palatin Technologies's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.05/4.46
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palatin Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Palatin Technologies's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.098/131.7762*131.7762
=0.098

Current CPI (Mar. 2024) = 131.7762.

Palatin Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201406 6.209 100.560 8.136
201409 6.836 100.428 8.970
201412 19.665 99.070 26.157
201503 14.224 99.621 18.815
201506 5.341 100.684 6.990
201509 7.436 100.392 9.761
201512 2.747 99.792 3.627
201603 -1.726 100.470 -2.264
201606 -6.412 101.688 -8.309
201609 -5.863 101.861 -7.585
201612 -2.990 101.863 -3.868
201703 -3.254 102.862 -4.169
201706 -0.804 103.349 -1.025
201709 0.810 104.136 1.025
201712 1.232 104.011 1.561
201803 1.308 105.290 1.637
201806 3.361 106.317 4.166
201809 3.100 106.507 3.835
201812 2.603 105.998 3.236
201903 1.978 107.251 2.430
201906 11.083 108.070 13.514
201909 10.554 108.329 12.838
201912 9.967 108.420 12.114
202003 9.454 108.902 11.440
202006 8.743 108.767 10.593
202009 8.372 109.815 10.046
202012 7.372 109.897 8.840
202103 6.833 111.754 8.057
202106 5.396 114.631 6.203
202109 4.644 115.734 5.288
202112 3.798 117.630 4.255
202203 3.029 121.301 3.291
202206 1.755 125.017 1.850
202209 0.909 125.227 0.957
202212 1.578 125.222 1.661
202303 0.860 127.348 0.890
202306 0.011 128.729 0.011
202309 -0.406 129.860 -0.412
202312 -0.796 129.419 -0.810
202403 0.098 131.776 0.098

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Palatin Technologies  (LTS:0KF3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Palatin Technologies Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Palatin Technologies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Palatin Technologies (LTS:0KF3) Business Description

Traded in Other Exchanges
Address
4B Cedar Brook Drive, Cranbury, NJ, USA, 08512
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Palatin Technologies (LTS:0KF3) Headlines

No Headlines